PT3459542T - Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal - Google Patents
Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminalInfo
- Publication number
- PT3459542T PT3459542T PT177996741T PT17799674T PT3459542T PT 3459542 T PT3459542 T PT 3459542T PT 177996741 T PT177996741 T PT 177996741T PT 17799674 T PT17799674 T PT 17799674T PT 3459542 T PT3459542 T PT 3459542T
- Authority
- PT
- Portugal
- Prior art keywords
- prevention
- treatment
- trigeminal neuralgia
- carbamate compound
- carbamate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061386 | 2016-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3459542T true PT3459542T (pt) | 2021-08-24 |
Family
ID=60325324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT177996741T PT3459542T (pt) | 2016-05-19 | 2017-05-18 | Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11207295B2 (enExample) |
| EP (1) | EP3459542B1 (enExample) |
| JP (1) | JP6960415B2 (enExample) |
| KR (1) | KR102421013B1 (enExample) |
| CN (1) | CN109310669B (enExample) |
| AU (1) | AU2017267160B2 (enExample) |
| CA (1) | CA3024284C (enExample) |
| DK (1) | DK3459542T3 (enExample) |
| ES (1) | ES2887338T3 (enExample) |
| MX (1) | MX389613B (enExample) |
| PL (1) | PL3459542T3 (enExample) |
| PT (1) | PT3459542T (enExample) |
| RU (1) | RU2751504C2 (enExample) |
| WO (1) | WO2017200317A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3035674T3 (en) | 2016-12-14 | 2025-09-08 | Sk Biopharmaceuticals Co Ltd | Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease |
| IL281559B2 (en) * | 2018-09-21 | 2025-06-01 | Sk Biopharmaceuticals Co Ltd | (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
| KR20210062029A (ko) | 2018-10-19 | 2021-05-28 | 에스케이바이오팜 주식회사 | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| DE2628420A1 (de) * | 1976-06-24 | 1978-01-05 | Bayer Ag | 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide |
| EP0959882A4 (en) * | 1996-12-31 | 2001-12-05 | N-BONDED UREAUTIES AND CARBAMATES OF HETEROCYCLIC THIOESTERS | |
| MXPA03007721A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuesto de carbamato para su uso en el tratamiento del dolor. |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| JP4227121B2 (ja) * | 2005-06-08 | 2009-02-18 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| KR20140009244A (ko) * | 2010-11-11 | 2014-01-22 | 애크런 몰레큘스 게엠베하 | 통증 치료용 화합물 및 방법 |
| SI3054950T1 (sl) * | 2014-05-09 | 2017-12-29 | Tecnimede-Sociedade Tecnico-Medicinal, S.A. | (r)-pirindol in njegove farmacevtsko sprejemljive soli za uporabo v medicini |
-
2017
- 2017-05-16 KR KR1020170060713A patent/KR102421013B1/ko active Active
- 2017-05-18 PL PL17799674T patent/PL3459542T3/pl unknown
- 2017-05-18 RU RU2018144784A patent/RU2751504C2/ru active
- 2017-05-18 AU AU2017267160A patent/AU2017267160B2/en active Active
- 2017-05-18 PT PT177996741T patent/PT3459542T/pt unknown
- 2017-05-18 ES ES17799674T patent/ES2887338T3/es active Active
- 2017-05-18 DK DK17799674.1T patent/DK3459542T3/da active
- 2017-05-18 US US16/302,860 patent/US11207295B2/en active Active
- 2017-05-18 WO PCT/KR2017/005172 patent/WO2017200317A1/ko not_active Ceased
- 2017-05-18 MX MX2018014081A patent/MX389613B/es unknown
- 2017-05-18 EP EP17799674.1A patent/EP3459542B1/en active Active
- 2017-05-18 CN CN201780030912.5A patent/CN109310669B/zh active Active
- 2017-05-18 JP JP2018560617A patent/JP6960415B2/ja active Active
- 2017-05-18 CA CA3024284A patent/CA3024284C/en active Active
-
2021
- 2021-12-02 US US17/457,308 patent/US12611395B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018073556A2 (pt) | 2019-03-19 |
| MX2018014081A (es) | 2019-09-02 |
| AU2017267160A1 (en) | 2018-12-13 |
| CN109310669A (zh) | 2019-02-05 |
| EP3459542A4 (en) | 2020-01-08 |
| US12611395B2 (en) | 2026-04-28 |
| KR20170131241A (ko) | 2017-11-29 |
| CN109310669B (zh) | 2022-02-22 |
| ES2887338T3 (es) | 2021-12-22 |
| RU2018144784A (ru) | 2020-06-19 |
| CA3024284A1 (en) | 2017-11-23 |
| EP3459542B1 (en) | 2021-06-30 |
| US20190175555A1 (en) | 2019-06-13 |
| RU2018144784A3 (enExample) | 2020-08-11 |
| JP2019516722A (ja) | 2019-06-20 |
| US11207295B2 (en) | 2021-12-28 |
| KR102421013B1 (ko) | 2022-07-14 |
| US20220087976A1 (en) | 2022-03-24 |
| DK3459542T3 (da) | 2021-09-13 |
| EP3459542A1 (en) | 2019-03-27 |
| PL3459542T3 (pl) | 2021-12-27 |
| MX389613B (es) | 2025-03-20 |
| CA3024284C (en) | 2024-01-23 |
| RU2751504C2 (ru) | 2021-07-14 |
| AU2017267160B2 (en) | 2022-11-10 |
| WO2017200317A1 (ko) | 2017-11-23 |
| JP6960415B2 (ja) | 2021-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269354A (en) | Compounds useful in the treatment or prevention of a prmt5-mediated disorder | |
| IL289423A (en) | Compounds and methods for treating neurological and cardiovascular conditions | |
| LT3334422T (lt) | Kanabidiolio rūgšties panaudojimas epilepsijos gydymui | |
| HUE039809T2 (hu) | Vegyület karbamid-tartalmú mûtrágyák kezelésére | |
| DK3507291T3 (da) | Kondenserede bicykliske sgc-stimulatorer | |
| EP3457850C0 (en) | SYNERGISTIC COMBINATION OF BIOCIDES | |
| IL264143B (en) | Processes for preparing olaparib | |
| DK3624796T3 (da) | Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse | |
| DK3504187T3 (da) | Anvendelse af pridopidin til behandling af funktionel tilbagegang | |
| IL247111A0 (en) | Preventive or therapeutic agent for kidney disease | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
| IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3331610T3 (da) | Midler til anvendelse til behandling af gliom | |
| DK3459543T3 (da) | Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi | |
| SI3522880T1 (sl) | Postopki zdravljenja akutne poškodbe ledvic | |
| IL282700A (en) | Heterocyclic compounds for the treatment of epilepsy | |
| DK3286317T3 (da) | Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi | |
| HUE059838T2 (hu) | Seladelpar primer epe cholangitis kezelésére | |
| PL3297625T3 (pl) | Związek do profilaktyki lub leczenia nefropatii cukrzycowej lub cukrzycowej choroby nerek | |
| LT3402474T (lt) | Il-8 inhibitoriai, skirti panaudoti chemoterapijos sukeltos periferinės neuropatijos gydymui | |
| DK3302573T3 (da) | Sammensætning til behandlingen af hjernelæsioner | |
| HUE042043T2 (hu) | Malária megelõzésére vagy kezelésére alkalmas triaminopiridin-vegyületek |